TOPICA Pharmaceuticals Receives $27,000,000 Series B Financing

  • Feed Type
  • Date
    10/18/2011
  • Company Name
    TOPICA Pharmaceuticals
  • Mailing Address
    435 Tasso Street Palo Alto, CA 94301
  • Company Description
    Topica Pharmaceuticals, Inc. is a privately held, clinical-stage specialty pharmaceutical company focused exclusively on developing the first highly effective, safe and convenient topical treatment for onychomycosis, or fungal infections of the toenail and nail bed.
  • Website
    http://www.topicapharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B round will be used for continued development of the company’s broad-spectrum topical antifungal agent.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    Yasuda Enterprise Development

By posting a comment, you agree to our terms and conditions.